status of coquí mo-99 medical isotope production facility · coquí’s goals •develop and...

12
Status of Coquí Mo-99 Medical Isotope Production Facility June 27, 2014 Blair Everett Coquí Radiopharmaceuticals Corp

Upload: others

Post on 08-Aug-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Status of Coquí Mo-99 Medical Isotope Production Facility

June 27, 2014

Blair Everett

Coquí Radiopharmaceuticals Corp

Page 2: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Current Situation

• U.S. depends on foreign imports of Mo-99

• Supply chain risk/age of current reactors could delay diagnosis and treatment for heart disease and cancer

Page 3: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Coquí’s Goals

• Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production facility utilizing proven technology that relies on LEU thus: 1. Providing a continuous source of Mo-99 for the

world’s nuclear medicine industry; 2. Advancing nuclear medicine by establishing a state

of the art production facility; 3. Contributing to national security by reducing the

need for exports of HEU; and 4. Bringing much needed employment, new sources of

industry and economic development.

Page 4: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Conceptual Medical Isotope Production Facility

Page 5: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Facility Overview

• The MIPF consists of:

– twin nuclear reactors that operate at less than 10 MW

– a radioisotope processing plant

– a waste conditioning plant

• LEU targets will be fissioned in the reactors, and then targets will be taken to the processing cells where Mo-99 will be extracted

• Approximate facility cost: $250 million

Page 6: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Site Description

• Alachua, FL

• ~25 acres in Progress Corporate Park

• Other surrounding land is agricultural/state park

• Closest major population center is Gainesville, 10 miles SE

Page 7: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Geotechnical and Hydrogeological Boring

Geophysics Heritage Tree Identification

Ecology Resource Survey

Site Investigation

7

Page 8: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Other Site Research/Fieldwork

• Outreach to tribal governments

• Socio and demographic data

• Climate and weather

• Cultural resources survey

Page 9: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Community Outreach

• Coordination with county, local, state government, Chamber of Commerce and University of Florida

Page 10: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Community Impact

• Construction

– 1,824 jobs

– $246 million total output to local economy

• Operations

– 285 jobs

– $31 million total output annually

Page 11: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Licensing

• Preliminary Safety Analysis Report (PSAR) and Environmental Report (ER), to be submitted to NRC by middle of 2015

• Construction permit issued by NRC following approval of PSAR and ER

Page 12: Status of Coquí Mo-99 Medical Isotope Production Facility · Coquí’s Goals •Develop and operate the first domestically dedicated Mo-99 and radioisotope pharmaceutical production

Conclusion

• Coquí is working quickly to ensure a reliable, secure domestic supply of Mo-99 using proven technology

• Questions?